404 related articles for article (PubMed ID: 12874016)
1. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
[TBL] [Abstract][Full Text] [Related]
2. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.
Bukur J; Rebmann V; Grosse-Wilde H; Luboldt H; Ruebben H; Drexler I; Sutter G; Huber C; Seliger B
Cancer Res; 2003 Jul; 63(14):4107-11. PubMed ID: 12874014
[TBL] [Abstract][Full Text] [Related]
3. HLA-G expression in malignant melanoma.
Rebmann V; Wagner S; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
[TBL] [Abstract][Full Text] [Related]
4. Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines.
Giacomini P; Giorda E; Fraioli R; Nicotra MR; Vitale N; Setini A; Delfino L; Morabito A; Benevolo M; Venturo I; Mottolese M; Ferrara GB; Natali PG
Cancer Res; 1999 Jun; 59(11):2657-67. PubMed ID: 10363989
[TBL] [Abstract][Full Text] [Related]
5. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis of HLA-C heavy chains in melanoma cells with multiple defects in the expression of HLA-A, -B, -C molecules.
Martayan A; Fraioli R; Giorda E; Setini A; Ciccarelli G; Delfino L; Ferrara GB; Giacomini P
Br J Cancer; 1999 May; 80(5-6):639-49. PubMed ID: 10360639
[TBL] [Abstract][Full Text] [Related]
7. Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications.
Raffaghello L; Prigione I; Bocca P; Morandi F; Camoriano M; Gambini C; Wang X; Ferrone S; Pistoia V
Oncogene; 2005 Jul; 24(29):4634-44. PubMed ID: 15897905
[TBL] [Abstract][Full Text] [Related]
8. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.
Raffaghello L; Nozza P; Morandi F; Camoriano M; Wang X; Garrè ML; Cama A; Basso G; Ferrone S; Gambini C; Pistoia V
Cancer Res; 2007 Jun; 67(11):5471-8. PubMed ID: 17545629
[TBL] [Abstract][Full Text] [Related]
9. The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma.
Paschen A; Arens N; Sucker A; Greulich-Bode KM; Fonsatti E; Gloghini A; Striegel S; Schwinn N; Carbone A; Hildenbrand R; Cerwenka A; Maio M; Schadendorf D
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3297-305. PubMed ID: 16740750
[TBL] [Abstract][Full Text] [Related]
10. [An immunocytochemical investigation of antigen expression by skin melanoma cells cultured for vaccine production].
Moiseenko VM; Danilova AB; Danilov AO; Turkevich EA; Baldueva IA; Matsko DE
Vopr Onkol; 2008; 54(3):303-14. PubMed ID: 18652234
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies.
Paul P; Cabestré FA; Le Gal FA; Khalil-Daher I; Le Danff C; Schmid M; Mercier S; Avril MF; Dausset J; Guillet JG; Carosella ED
Cancer Res; 1999 Apr; 59(8):1954-60. PubMed ID: 10213506
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight protein (LMP)2/LMP7 abnormality underlies the downregulation of human leukocyte antigen class I antigen in a hepatocellular carcinoma cell line.
Shen YQ; Zhang JQ; Xia M; Miao FQ; Shan XN; Xie W
J Gastroenterol Hepatol; 2007 Jul; 22(7):1155-61. PubMed ID: 17608862
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.
Ohnmacht GA; Marincola FM
J Cell Physiol; 2000 Mar; 182(3):332-8. PubMed ID: 10653599
[TBL] [Abstract][Full Text] [Related]
14. Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines.
Méndez R; Rodríguez T; Del Campo A; Monge E; Maleno I; Aptsiauri N; Jiménez P; Pedrinaci S; Pawelec G; Ruiz-Cabello F; Garrido F
Cancer Immunol Immunother; 2008 May; 57(5):719-29. PubMed ID: 17934731
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P
Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559
[TBL] [Abstract][Full Text] [Related]
16. The role of surface HLA-A,B,C molecules in tumour immunity.
Möller P; Hämmerling GJ
Cancer Surv; 1992; 13():101-27. PubMed ID: 1423320
[TBL] [Abstract][Full Text] [Related]
17. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines.
Marincola FM; Shamamian P; Alexander RB; Gnarra JR; Turetskaya RL; Nedospasov SA; Simonis TB; Taubenberger JK; Yannelli J; Mixon A
J Immunol; 1994 Aug; 153(3):1225-37. PubMed ID: 8027550
[TBL] [Abstract][Full Text] [Related]
18. HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank.
Mendez R; Aptsiauri N; Del Campo A; Maleno I; Cabrera T; Ruiz-Cabello F; Garrido F; Garcia-Lora A
Cancer Immunol Immunother; 2009 Sep; 58(9):1507-15. PubMed ID: 19340423
[TBL] [Abstract][Full Text] [Related]
19. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker.
Ogino T; Shigyo H; Ishii H; Katayama A; Miyokawa N; Harabuchi Y; Ferrone S
Cancer Res; 2006 Sep; 66(18):9281-9. PubMed ID: 16982773
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of HLA class I molecules in primary oral squamous cell carcinomas and cell lines.
Tang Q; Zhang J; Qi B; Shen C; Xie W
Arch Med Res; 2009 May; 40(4):256-63. PubMed ID: 19608014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
